Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Versican (VCAN) Proteolysis Predicts Survival in Multiple Myeloma (MM) after High Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT/AHCT)

Binod Dhakal, MBBS, Muhammad Umair Mushtaq, MD, Ashley Cunningham, MD, Athanasios Papadas, MD, Adam Pagenkopf, BS, Joshua Wiesner, Catherine Leith, MBBChir, Peiman Hematti, MD, Parameswaran Hari, MBBS, MD, Natalie Scott Callander, MD, Fotis Asimakopoulos, PhDMBBChir,

Blood (2019) 134 (Supplement_1): 3088.

https://doi.org/10.1182/blood-2019-127565

Published: 2019

Journal Articles

Factors Associated with Bleeding Events in Patients Receiving Rivaroxaban for Venous Thromboembolism: A Real World Experience

Ankit Mangla, MBBS, MD, Muhammad Umair Mushtaq, MD, Koosha Paydary, MD, Hashim Mann, MD, Jiaxiang Liu, MD, Jayasree Krishnan, MD, Tauseef Akhtar, MD, Jishanth Mattumpuram, MD, Aakash Putta, MD, Alok Uprety, MD, Yanting Wang, MD, Barbra Yim, PharmD, Thomas Lad, MD

Blood (2018) 132 (Supplement 1): 5064.

https://doi.org/10.1182/blood-2018-99-110983

Published: 2018

Journal Articles

Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Relapsed/Refractory Acute Myeloid Leukemia

Muhammad Umair Mushtaq, MD, Sibgha Gull Chaudhary, MD, Guru Subramanian Guru Murthy, MBBS, Aric C. Hall, MD, Ehab L. Atallah, MD, Ryan J. Mattison, MD

Blood (2018) 132 (Supplement 1): 5246.

https://doi.org/10.1182/blood-2018-99-112204

Published: 2018

Journal Articles

Comparison of Salvage Chemotherapy Regimens in Relapsed/Refractory Acute Myeloid Leukemia

Muhammad Umair Mushtaq, MD, Sibgha Gull Chaudhary, MD, Laura C. Michaelis, MD, Karen-Sue B. Carlson, MD PhD, Sameem Abedin, MD, Lyndsey Runass, MD, Michael J. Fallon, PharmD, Alexandra M. Harrington, MD, Mark Juckett, MD, Aric C. Hall, MD, Ryan J. Mattison, MD, Ehab L. Atallah, MD, Guru Subramanian Guru Murthy, MBBS

Blood (2018) 132 (Supplement 1): 2708.

https://doi.org/10.1182/blood-2018-99-113764

Published: 2018

Journal Articles

Prognostic Significance of Bone Marrow Involvement in Hodgkin Lymphoma

Ankit Mangla, MBBS, MD, Muhammad Umair Mushtaq, MD, Rohit Kumar, MD, Nikki Agarwal, MD, Sibgha Gull Chaudhary, MBBS, Rosalind Catchatourian, MD

Blood (2016) 128 (22): 5370.

https://doi.org/10.1182/blood.V128.22.5370.5370

Published: 2016

NARROW

Versican (VCAN) Proteolysis Predicts Survival in Multiple Myeloma (MM) after High Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT/AHCT)

Factors Associated with Bleeding Events in Patients Receiving Rivaroxaban for Venous Thromboembolism: A Real World Experience

Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Relapsed/Refractory Acute Myeloid Leukemia

Comparison of Salvage Chemotherapy Regimens in Relapsed/Refractory Acute Myeloid Leukemia

Prognostic Significance of Bone Marrow Involvement in Hodgkin Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Versican (VCAN) Proteolysis Predicts Survival in Multiple Myeloma (MM) after High Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT/AHCT)

Factors Associated with Bleeding Events in Patients Receiving Rivaroxaban for Venous Thromboembolism: A Real World Experience

Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Relapsed/Refractory Acute Myeloid Leukemia

Comparison of Salvage Chemotherapy Regimens in Relapsed/Refractory Acute Myeloid Leukemia

Prognostic Significance of Bone Marrow Involvement in Hodgkin Lymphoma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only